StreetInsider.com News Articles

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

Tue, 08 Sep 2026 06:00:00 -0400

Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App

TAMPA, FL / ACCESS Newswire / September 8, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,and Tollo Health, LLC ("Tollo"), a proprietary medical foods and nutraceutical manufacturer, today announced they have jointly entered into a partnership with

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

Tue, 08 Sep 2026 06:00:00 -0400

Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

Tue, 08 Sep 2026 06:00:00 -0400

Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

Tue, 08 Sep 2026 06:00:00 -0400

Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App

CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

Thu, 27 Aug 2026 09:30:00 -0400

This version includes the correct image.

50% off available online at www.TolloHealth.Shop and www.CorexaRx.com
Soon to become available at Health Lives Here™ pharmacies and on Amazon.com

TAMPA, FL / ACCESS Newswire / August 27, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the tokenization of pharmaceutical serialization and the compliant delivery of healthcare and monetization of health data,

CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

Thu, 27 Aug 2026 09:30:00 -0400

This version includes the correct image.

50% off available online at www.TolloHealth.Shop and www.CorexaRx.com
Soon to become available at Health Lives Here™ pharmacies and on Amazon.com

DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

Thu, 27 Aug 2026 08:55:00 -0400

50% off available online at www.TolloHealth.Shop and www.CorexaRx.com
Soon to become available at Health Lives Here™ pharmacies and on Amazon.com

DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

Thu, 27 Aug 2026 08:55:00 -0400

50% off available online at www.TolloHealth.Shop and www.CorexaRx.com
Soon to become available at Health Lives Here™ pharmacies and on Amazon.com

Form 8-K DataMeds AI, Inc. For: Aug 17

Tue, 18 Aug 2026 07:43:00 -0400

si-local-file:///var/storage/secattach/20260818/26940596.html

Form 8-K DataMeds AI, Inc. For: Aug 17

Tue, 18 Aug 2026 07:43:00 -0400

si-local-file:///var/storage/secattach/20260818/26940596.html

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Mon, 17 Aug 2026 09:00:00 -0400

Revenues grew 14% reaching $1.779M in Q2/26, beating management projections
Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to 'MEDS' on NASDAQ Capital Markets
$6.5 million new funding in June 2026 provided capital to support corporate turnaround
Pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Mon, 17 Aug 2026 09:00:00 -0400

Revenues grew 14% reaching $1.779M in Q2/26, beating management projections
Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to 'MEDS' on NASDAQ Capital Markets
$6.5 million new funding in June 2026 provided capital to support corporate turnaround
Pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Mon, 17 Aug 2026 09:00:00 -0400

Revenues grew 14% reaching $1.779M in Q2/26, beating management projections
Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to 'MEDS' on NASDAQ Capital Markets
$6.5 million new funding in June 2026 provided capital to support corporate turnaround
Pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Mon, 17 Aug 2026 09:00:00 -0400

Revenues grew 14% reaching $1.779M in Q2/26, beating management projections
Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to 'MEDS' on NASDAQ Capital Markets
$6.5 million new funding in June 2026 provided capital to support corporate turnaround
Pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience

Form 10-Q DataMeds AI, Inc. For: Jun 30

Mon, 17 Aug 2026 06:08:00 -0400
si-local-file:///var/storage/secattach/20260817/26934355.html

Form 10-Q DataMeds AI, Inc. For: Jun 30

Mon, 17 Aug 2026 06:08:00 -0400
si-local-file:///var/storage/secattach/20260817/26934355.html

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock

Fri, 14 Aug 2026 17:25:00 -0400

TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today announced that its board of directors (the "Board") fixed September 9, 2026 (the "Payment Date") as the date on which the previously announced distribution (the "Distribution") of Dream Bowl Meme Coin I

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock

Fri, 14 Aug 2026 17:25:00 -0400

TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today announced that its board of directors (the "Board") fixed September 9, 2026 (the "Payment Date") as the date on which the previously announced distribution (the "Distribution") of Dream Bowl Meme Coin I

Form 8-K DataMeds AI, Inc. For: Aug 14

Fri, 14 Aug 2026 16:46:00 -0400
si-local-file:///var/storage/secattach/20260814/26932064.html

Form 8-K DataMeds AI, Inc. For: Aug 14

Fri, 14 Aug 2026 16:46:00 -0400
si-local-file:///var/storage/secattach/20260814/26932064.html

Form NT 10-Q DataMeds AI, Inc. For: Jun 30

Fri, 14 Aug 2026 16:23:00 -0400
si-local-file:///var/storage/secattach/20260814/26930971.html

Form NT 10-Q DataMeds AI, Inc. For: Jun 30

Fri, 14 Aug 2026 16:23:00 -0400
si-local-file:///var/storage/secattach/20260814/26930971.html

DataMeds AI unit reports $600K monthly revenue and new GLP-1 drugs

Wed, 12 Aug 2026 07:40:43 -0400

DataMeds AI, Inc. (NASDAQ: MEDS) reported that its pharmacy subsidiary, Corexa Pharmacy, generated more than $600,000 in revenue in July 2026, placing its annualized run rate above $7 million, according to a press release from the company.
Corexa Pharmacy, recently rebranded from Wellgistics Pharmacy, has registered with TrumpRx to offer patients access to oral GLP-1 agonist drugs, including Eli Lilly's Foundayo and Novo Nordisk's oral Wegovy, with out-of-pocket costs starting at $149. Injectable GLP-1 agonist drugs are also now available through the pharmacy.
The company said it has integrated its online store, CorexaRx.com, into the Health Lives Here mobile app, available on

DataMeds AI Provides Update on Corexa Health's Pharmacy Division

Wed, 12 Aug 2026 07:40:00 -0400

GLP-1 agonist drugs now available
Integration of online store CorexaRx.com into Health Lives Here app now complete
Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available
Revenue stabilized above $600,000 for July 2026 amid rebranding as pharmacy prepares to expand through the launch of Health Lives Here app with NFL Alumni Health

TAMPA, FL / ACCESS Newswire / August 12, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart

DataMeds AI Provides Update on Corexa Health's Pharmacy Division

Wed, 12 Aug 2026 07:40:00 -0400

GLP-1 agonist drugs now available
Integration of online store CorexaRx.com into Health Lives Here app now complete
Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available
Revenue stabilized above $600,000 for July 2026 amid rebranding as pharmacy prepares to expand through the launch of Health Lives Here app with NFL Alumni Health

TAMPA, FL / ACCESS Newswire / August 12, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart